Literature DB >> 28623931

Retinal involvement in sepsis: from the eye of the patient to the eye of the beholder.

E Christiaan Boerma1.   

Abstract

Entities:  

Keywords:  Fluorescence angiography; Retinal blood flow; Roth spot; Sepsis

Mesh:

Year:  2017        PMID: 28623931      PMCID: PMC5474021          DOI: 10.1186/s13054-017-1721-2

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
In the history of mankind the importance of the eye has always extended beyond the organ itself. In ancient Egypt the “Eye of Horus” represented royal power and good health and reflected all six senses. In Greek mythology the symbolic value of the eye was already supported by detailed medical knowledge [1]. Not only symbolizing the giant one-eyed cyclops’ limited intelligence in contrast to the vigilance of Panoptes, whose body was covered by eye’s, the stories also reflected the understanding of the concepts of visual fields and acuity. In modern ophthalmology the idea of ocular involvement in systemic diseases, such as lupus and diabetes, is well established. In addition, the eye is also known as an organ that “mirrors” diseases in a distant primary organ of interest; Roth spots in endocarditis is the classic example [2]. In a recently published paper in Critical Care Erikson and co-workers extended these ideas to the context of sepsis [3]. They added direct observation of the retina to the already many-headed sepsis Hydra, which affects so many organs. Retinal fluorescein angiography was performed twice during the first 5 days in the intensive care unit in 31 patients with sepsis. In addition ocular pressure was determined. By doing so the authors demonstrated the feasibility of this technique in the local ICU setting, despite practical limitations. And the results were alarming. More than half of the patients displayed signs of retinal pathology, including fluorescein-leaking retinal micro-aneurysms, vitreous hemorrhages, and other retinal hemorrhages. These findings were bilateral in 75% of the affected cases. Ocular hypertension was present in 16% of all septic patients. Such abnormalities were increasingly present in the subgroup of septic patients with a slowdown of arterial retinal blood flow, expressed as a prolonged retinal arterial filling time >8.3 s. In general these patients were sicker and had lower cardiac output. This led the authors to believe that retinal fluorescein angiography has potential to detect and characterize sepsis in a non-invasive way (with the exception of an intravenous fluorescent dye, that is). But as tempting as it may seem, such a search for the holy grail of an easily accessible organ that “represents” (all) other organs carries the risk of oversimplification. Recent examples of tonometry as a “canary of the body” and the sublingual microcirculation as a window for other organs remind us to be cautious [4, 5], especially in a disease state that is characterized by heterogeneity of blood flow within and between organs [6]. In addition, the idea to use retinal microvascular blood flow as a surrogate for intracranial perfusion is equally tempting. Previous observations have suggested that both retinal and conjunctival blood flow may, to some extent, represent cerebral blood flow changes during carotid endarterectomy [7, 8]. Others observed that retinal blood flow may reflect intracranial hypertension [9]. However, the absence of abolishment of conjunctival blood flow during angiography-proven brain death is reason to use the eye as a window for the brain with great caution [10]. Where should we go from here? Irrespective of the issue of retinal pathology as a surrogate for the effects of sepsis in other organs, what is the relevance of the findings in themselves. If more than half of sepsis patients have retinal pathology, what are the clinical consequences? Are they related to visual outcome? And do they need follow-up? The fact that, in this study, the abnormal retinal findings had resolved in a control angiography 3–6 months after hospital discharge in surviving patients is seemingly reassuring, but these need to be confirmed in larger high-risk patient cohorts. In addition it is known that processes other than sepsis, such as hypoxia or ischemia, may also upset the normal retina–blood barrier in the retinal capillaries, thereby allowing extravascular leakage of fluorescein. This warrants further studies to establish the incidence of retinal pathology in other high-risk ICU populations. And what about post-ICU check-ups for intraocular hypertension, usually unnoticed by the patient until irreversible visual damage has occurred. With an increasing ICU survival rate even for very complicated disease states such as sepsis, the ICU community is becoming more and more aware of post-ICU sequelae, also referred to as post-intensive care syndrome (PICS) [11]. In addition to ICU-acquired weakness and cognitive impairment, even a small deterioration in visual abilities may be very relevant for daily life activities, especially in the frail elderly with a pre-existing decline in function of potentially all six senses prior to and after ICU admission [12]. We thank doctor Erikson and his colleagues for their effort to cross the (imaginary) border between the ICU and the ophthalmology department. Their innovative research has made the ICU community aware of the fact that sepsis, and potentially other critically ill disease states, may affect the eyes of ICU patients. Undoubtedly this will change the eye of the beholder as well.
  11 in total

1.  'Death and life are in the power of the tongue'?

Authors:  Edo Kaluski; Olga Milo-Cotter; Gad Cotter
Journal:  Cardiology       Date:  2009-04-09       Impact factor: 1.869

2.  Clinical assessment of noninvasive intracranial pressure absolute value measurement method.

Authors:  A Ragauskas; V Matijosaitis; R Zakelis; K Petrikonis; D Rastenyte; I Piper; G Daubaris
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

3.  Improved gastric tonometry for monitoring tissue perfusion: the canary sings louder.

Authors:  S A Garrett; R G Pearl
Journal:  Anesth Analg       Date:  1996-07       Impact factor: 5.108

4.  Noninvasive analysis of conjunctival microcirculation during carotid artery surgery reveals microvascular evidence of collateral compensation and stenosis-dependent adaptation.

Authors:  K-D Schaser; U Settmacher; G Puhl; L Zhang; T Mittlmeier; J F Stover; B Vollmar; M D Menger; P Neuhaus; N P Haas
Journal:  J Vasc Surg       Date:  2003-04       Impact factor: 4.268

5.  Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis.

Authors:  E Christiaan Boerma; Peter H J van der Voort; Peter E Spronk; Can Ince
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

Review 6.  Hearing loss in older critical care patients: participation in decision making.

Authors:  Sonya R Hardin
Journal:  Crit Care Nurse       Date:  2012-12       Impact factor: 1.708

7.  Poor functional status immediately after discharge from an intensive care unit.

Authors:  Marike van der Schaaf; Daniela S Dettling; Anita Beelen; Cees Lucas; Dave A Dongelmans; Frans Nollet
Journal:  Disabil Rehabil       Date:  2008       Impact factor: 3.033

8.  Greek mythology: the eye, ophthalmology, eye disease, and blindness.

Authors:  Constantinos Trompoukis; Dimitrios Kourkoutas
Journal:  Can J Ophthalmol       Date:  2007-06       Impact factor: 1.882

9.  Conjunctival microcirculatory blood flow is altered but not abolished in brain dead patients: a prospective observational study.

Authors:  Tomas Tamosuitis; Andrius Pranskunas; Neringa Balciuniene; Vidas Pilvinis; E Christiaan Boerma
Journal:  BMC Neurol       Date:  2016-07-11       Impact factor: 2.474

10.  Retinal arterial blood flow and retinal changes in patients with sepsis: preliminary study using fluorescein angiography.

Authors:  Kristo Erikson; Janne Henrik Liisanantti; Nina Hautala; Juha Koskenkari; Remi Kamakura; Karl Heinz Herzig; Hannu Syrjälä; Tero Ilmari Ala-Kokko
Journal:  Crit Care       Date:  2017-04-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.